Toxicity Study of Streptococcus pneumoniae Vaccine Administrated Subcutaneously in Rats

This study was performed to evaluate the toxicity of polysaccharide-based Streptococcus pneumoniae vaccine in Specific Pathogen Free (SPF), Sprague-Dawley (SD) rats. S. pneumoniae vaccine was administrated subcutaneously each dose level of high (560 ㎍/rat), medium (280 ㎍/rat) and low (140 ㎍/rat) on...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicological research (Seoul) 2011, 27(2), , pp.111-118
Hauptverfasser: Park, S.J., Jellanamdo Biopharmaceutical Research Center, Hwasun, Republic of Korea, Seo, K.H., Jellanamdo Biopharmaceutical Research Center, Hwasun, Republic of Korea, Han, S.I., Jellanamdo Biopharmaceutical Research Center, Hwasun, Republic of Korea
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study was performed to evaluate the toxicity of polysaccharide-based Streptococcus pneumoniae vaccine in Specific Pathogen Free (SPF), Sprague-Dawley (SD) rats. S. pneumoniae vaccine was administrated subcutaneously each dose level of high (560 ㎍/rat), medium (280 ㎍/rat) and low (140 ㎍/rat) on days 0, 14, 28. The rats were observed for 2 weeks or 4 weeks after the final injection. During this test, there were no significant dose-dependent changes in body weight, water and food consumption. In urinalysis and serum chemistry, dose-related changes were not detected. In hematology, the percent of neutrophils and lymphocytes in white blood cells were changed significantly. According to the measurement of organ weight, only spleen weight was significantly increased in all groups of administration compared to the control group. In the histopathological examination, an antigen-deposit, vacuolated macrophages, infiltrated inflammatory cells and a formation of granulation tissue were observed at the site of an administration. These results are considered as an outcome by immune responses through a vaccination. Consequently, the results of this study demonstrated that S. pneumoniae vaccine has no toxicity when it was administrated subcutaneously three times in 2-week interval at a high dose of 560 ㎍/rat.
ISSN:1976-8257
2234-2753
DOI:10.5487/TR.2011.27.2.111